These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27341308)

  • 1. Efficient Quantitative Analysis of Carboxyalkylpyrrole Ethanolamine Phospholipids: Elevated Levels in Sickle Cell Disease Blood.
    Guo J; Wang H; Hrinczenko B; Salomon RG
    Chem Res Toxicol; 2016 Jul; 29(7):1187-97. PubMed ID: 27341308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and biological activities of carboxyethylpyrrole ethanolamine phospholipids (CEP-EPs).
    Wang H; Guo J; West XZ; Bid HK; Lu L; Hong L; Jang GF; Zhang L; Crabb JW; ; Linetsky M; Salomon RG
    Chem Res Toxicol; 2014 Dec; 27(12):2015-22. PubMed ID: 25380349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Hydroxy-7-oxo-5-heptenoic Acid (HOHA) Lactone is a Biologically Active Precursor for the Generation of 2-(ω-Carboxyethyl)pyrrole (CEP) Derivatives of Proteins and Ethanolamine Phospholipids.
    Wang H; Linetsky M; Guo J; Choi J; Hong L; Chamberlain AS; Howell SJ; Howes AM; Salomon RG
    Chem Res Toxicol; 2015 May; 28(5):967-77. PubMed ID: 25793308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins.
    Kaur K; Salomon RG; O'Neil J; Hoff HF
    Chem Res Toxicol; 1997 Dec; 10(12):1387-96. PubMed ID: 9437530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
    Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
    Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
    Elshazly SA; Heiba NM; Abdelmageed WM
    Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
    Setty BN; Chen D; Stuart MJ
    Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel.
    Ohno K; Tanaka H; Samata N; Jakubowski JA; Tomizawa A; Mizuno M; Sugidachi A
    Thromb Res; 2014 Oct; 134(4):889-94. PubMed ID: 25130912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays.
    Noubouossie DC; Lê PQ; Rozen L; Debaugnies F; Ferster A; Demulder A
    Thromb Res; 2012 Aug; 130(2):259-64. PubMed ID: 22079446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profile of sickle cell disease in Oman.
    Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
    Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-dose warfarin on D-dimer levels during sickle cell vaso-occlusive crisis: a brief report.
    Ahmed S; Siddiqui AK; Iqbal U; Sison CP; Shahid RK; Sheth M; Patel DV; Russo LA
    Eur J Haematol; 2004 Mar; 72(3):213-6. PubMed ID: 14962240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of substance P are elevated in patients with sickle cell disease and increase further during vaso-occlusive crisis.
    Michaels LA; Ohene-Frempong K; Zhao H; Douglas SD
    Blood; 1998 Nov; 92(9):3148-51. PubMed ID: 9787150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Ischemia-Modified Albumin Levels and Dynamic Thiol/Disulfide Balance in Sickle Cell Disease: A Case-Control Study.
    Özcan O; Erdal H; İlhan G; Demir D; Gürpınar AB; Neşelioğlu S; Erel Ö
    Turk J Haematol; 2018 Nov; 35(4):265-270. PubMed ID: 30182924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease.
    Buchowski MS; Swift LL; Akohoue SA; Shankar SM; Flakoll PJ; Abumrad N
    JPEN J Parenter Enteral Nutr; 2007; 31(4):263-8. PubMed ID: 17595432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive 4-Oxoheptanedioic Monoamide Derivatives of Proteins and Ethanolaminephospholipids: Products of Docosahexaenoate Oxidation.
    Guo J; Hong L; West XZ; Wang H; Salomon RG
    Chem Res Toxicol; 2016 Oct; 29(10):1706-1719. PubMed ID: 27618287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GlycA is not a useful biomarker of inflammation in sickle cell disease.
    Weisman JK; Meeks D; Mendelsohn L; Remaley AT; Sampson M; Allen DT; Nichols J; Shet AS; Thein SL
    Int J Lab Hematol; 2018 Dec; 40(6):704-709. PubMed ID: 30152174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
    Tantawy AA; Adly AA; Ismail EA
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
    Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
    Tavakkoli F; Nahavandi M; Wyche MQ; Perlin E
    Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.